TSA and nicotinamide, both HDAC inhibitors, were separately used to reduce TNF-α which in turn reduces IL-6 expression in macrophages isolated from the PBMCs of RA patients (Gillespie et al., 2012). This evidence concerns the gene HDAC9 and rheumatoid arthritis.